Natera, Inc. financial data

Symbol
NTRA on Nasdaq
Industry
Services-Medical Laboratories
Location
13011 Mccallen Pass, Building A Suite 100, Austin, TX
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 416 % +2.57%
Quick Ratio 14 % -1.75%
Debt-to-equity 68.4 % -28.1%
Return On Equity -20.6 % +66.9%
Return On Assets -12.2 % +61.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 135M shares +10.1%
Common Stock, Shares, Outstanding 133M shares +10.9%
Entity Public Float 13.2B USD +150%
Common Stock, Value, Issued 12K USD +9.09%
Weighted Average Number of Shares Outstanding, Basic 125M shares +8.45%
Weighted Average Number of Shares Outstanding, Diluted 125M shares +8.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.7B USD +56.7%
Research and Development Expense 404M USD +26%
Costs and Expenses 1.92B USD +25.5%
Operating Income (Loss) -222M USD +50.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -190M USD +56.3%
Income Tax Expense (Benefit) 695K USD +156%
Net Income (Loss) Attributable to Parent -190M USD +56.2%
Earnings Per Share, Basic -1.53 USD/shares +59.5%
Earnings Per Share, Diluted -1.53 USD/shares +59.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Marketable Securities, Current 22.7M USD -90.4%
Accounts Receivable, after Allowance for Credit Loss, Current 314M USD +12.9%
Inventory, Net 44.7M USD +9.78%
Assets, Current 1.38B USD +9.32%
Property, Plant and Equipment, Net 162M USD +45.7%
Operating Lease, Right-of-Use Asset 86.1M USD +52.4%
Other Assets, Noncurrent 36.7M USD +138%
Assets 1.66B USD +15.2%
Accounts Payable, Current 34.9M USD +133%
Employee-related Liabilities, Current 62.1M USD +35.5%
Contract with Customer, Liability, Current 19.8M USD +18.9%
Liabilities, Current 344M USD +12%
Contract with Customer, Liability, Noncurrent 16.8M USD -12%
Operating Lease, Liability, Noncurrent 96.6M USD +44.1%
Liabilities 465M USD -31.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -344K USD +88.8%
Retained Earnings (Accumulated Deficit) -2.57B USD -8.01%
Stockholders' Equity Attributable to Parent 1.2B USD +56.2%
Liabilities and Equity 1.66B USD +15.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 27M USD
Net Cash Provided by (Used in) Financing Activities 6.47M USD +181%
Net Cash Provided by (Used in) Investing Activities 138M USD +771%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 133M shares +10.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 946M USD +47.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.18M USD +4.89%
Deferred Tax Assets, Valuation Allowance 747M USD +16.8%
Deferred Tax Assets, Gross 773M USD +18%
Operating Lease, Liability 107M USD +35.7%
Depreciation 6.3M USD +23.5%
Payments to Acquire Property, Plant, and Equipment 20.3M USD +78.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -188M USD +55.5%
Lessee, Operating Lease, Liability, to be Paid 141M USD +41.3%
Property, Plant and Equipment, Gross 240M USD +43.6%
Operating Lease, Liability, Current 10.2M USD -12.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17.8M USD +5.39%
Lessee, Operating Lease, Liability, to be Paid, Year One 17.5M USD +5.91%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 33.8M USD +62.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.1M USD -0.83%
Deferred Tax Assets, Operating Loss Carryforwards 395M USD -1.04%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 34.9M USD +13%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.4M USD +22.6%
Operating Lease, Payments 16.8M USD +35.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 7.06M USD +39.1%
Deferred Tax Assets, Net of Valuation Allowance 25.7M USD +66.4%
Share-based Payment Arrangement, Expense 274M USD +43.1%
Interest Expense 10.7M USD -15.5%